Clinical Trial: Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107

U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07292571) titled 'Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107' on Dec. 01.

Brief Summary: The study should evaluate the [99mTc]Tc -ZHER2:4107 accumulation in primary tumour of breast cancer patients with different HER2 expression

Study Start Date: Oct. 20

Study Type: INTERVENTIONAL

Condition: Primary Breast Cancer

Intervention: DRUG: Injection of [99mTc]Tc-ZHER2:4107, SPECT/CT

One single injection of [99mTc]Tc-ZHER2:4107, followed by SPECT/CT imaging 2 hours after injection

Recruitment Status: ENROLLING_BY_INVITATION

Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sc...